TrademarkDir
VESALIUS
LIVE

Serial Number

97055930

Owner

VESALIUS THERAPEUTICS INC.

Attorney

Christina M. Licursi

First Use Date

Dec 10, 2024

Filing Date

Oct 1, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

VESALIUS Trademark

Serial Number: 97055930 • Registration: 7827312

VESALIUS is a trademark filed by VESALIUS THERAPEUTICS INC. on October 1, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

VESALIUS THERAPEUTICS INC. (4 trademarks)

CAMBRIDGE, MA 02142

Entity Type: 03

Serqet Therapeutics, Inc. (3 trademarks)

Bldg 600/700 Suite 7-201
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

October 1, 2021

Registration Date

June 10, 2025

First Use Anywhere

December 10, 2024

First Use in Commerce

December 10, 2024

Published for Opposition

September 27, 2022

Goods & Services

Pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders

Research and development of pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders; pharmaceutical research and development

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 10, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 10, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 20, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 20, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 20, 2025 SUPC
USE AMENDMENT FILED
Mar 27, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 27, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 4 GRANTED
Nov 20, 2024 EX4G
SOU EXTENSION 4 FILED
Nov 20, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 20, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 21, 2024 EXRA
SOU EXTENSION 3 GRANTED
May 20, 2024 EX3G
SOU EXTENSION 3 FILED
May 20, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
May 20, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 18, 2023 EXRA
SOU EXTENSION 2 GRANTED
Nov 16, 2023 EX2G
SOU EXTENSION 2 FILED
Nov 16, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 16, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 19, 2023 EXRA
SOU EXTENSION 1 GRANTED
May 17, 2023 EX1G
SOU EXTENSION 1 FILED
May 17, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
May 17, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 22, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 27, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 27, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 7, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 25, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 18, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 17, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 7, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 7, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jul 7, 2022 CNRT
ASSIGNED TO EXAMINER
Jul 5, 2022 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 19, 2022 ASGN
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 28, 2021 NWOS

Related Trademarks

More from this Owner

DIAMOND

DIAMOND

SERQET THERAPEUTICS

SERQET THERAPEUTICS

SERQET

SERQET

SERQET THERAPEUTICS

SERQET THERAPEUTICS

SERQET THERAPEUTICS

SERQET THERAPEUTICS

SERQET

SERQET